|Titre :||National treatment plan for substance use disorder 2020|
|Titre de série :||National drug control strategy|
|Type de document :||Rapport|
|Editeur :||Washington, DC : The White House, 2020|
|Autre Editeur :||Washington, DC : ONDCP|
|Format :||18 p.|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASETRAITEMENT ; ACCES AUX SOINS ; PLANIFICATION SANITAIRE ; PRISE EN CHARGE ; INTERVENTION ; QUALITE ; PRODUIT ILLICITE ; OPIOIDES ; ALCOOL
According to the National Survey on Drug Use and Health (NSDUH), in 2018 an estimated 21.2 million Americans aged 12 and older needed treatment for a substance use disorder (SUD), but only 3.7 million received any kind of treatment and only 2.4 million received treatment at a specialty facility - a disparity known as the "treatment gap".
The Treatment Plan addresses the many reasons for this treatment gap. Many Americans cannot access treatment due to provider shortages and financial barriers, and others do not seek help because they are unaware of the severity of their drug use or are dissuaded by the stigma of addiction. The Treatment Plan supports strategies to encourage healthcare providers to screen for SUD so their patients can receive appropriate treatment. It also seeks to alleviate patients' financial barriers by working with health insurers in the private and public sectors to pay for life-saving treatment. Additionally, it seeks to explore innovative healthcare delivery strategies like telemedicine, support strategies to build the addiction workforce, and continue to combat the stigma of addiction.
|Domaine :||Drogues illicites / Illicit drugs|